AstraZeneca, Daiichi Sankyo's Experimental Lung Cancer Drug Shows Improvement in Patients

By Helena Smolak


AstraZeneca said its experimental drug for non-small cell lung cancer, jointly developed with Japan's Daiichi Sankyo, showed improvement in progression-free survival in its...

Related Keywords

Sweden ,Japan ,United Kingdom ,Swedish ,British ,Daiichi Sankyo ,Helena Smolak ,Susan Galbraith ,Astrazeneca ,Dow Jones ,